Cost‑effectiveness of atezolizumab as adjuvant therapy following resection for early‑stage， PD‑L1‑high， EGFR/ALK‑negative NSCLC
ZHANG Liang, ZHOU Qiuyun, WANG Jie, HOU Wenjie
Chinese Journal of Hospital Pharmacy . 2026, (7): 773 -778 .  DOI: 10.13286/j.1001-5213.2026.07.06

Information
Governed by: China Association for Science and Technology
Sponsored by: Chinese Pharmaceutical Association
Published by: Editorial Office of Chinese Journal of Hospital Pharmacy
ISSN 1001-5213
CN 42-1204/R
Contact
Website Copyright © Chinese Journal of Hospital Pharmacy, All Rights Reserved.
Tel: 027-82836596
E-mail：pharmacy@vip.163.com
Wechat